Showing 1 - 16 results of 16 for search 'R T Alekperov', query time: 0.02s Refine Results
  1. 1
    Raynaud’s phenomenon in the rheumatologist’s practice

    Raynaud’s phenomenon in the rheumatologist’s practice by R.T. Alekperov

    Published 2014-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Sildenafil in the treatment of Raynaud’s syndrome

    Sildenafil in the treatment of Raynaud’s syndrome by R T Alekperov

    Published 2009-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Intravenous immunoglobulin for intensive therapy of fibrosing alveolitis in a patient TOC \o "1-5" \h \z with systemic sclerosis

    Intravenous immunoglobulin for intensive therapy of fibrosing alveolitis in a patient TOC \o "1-5" \h \z with systemic sclerosis by R T Alekperov, Н Г Гусева

    Published 2004-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Autologous hematopoietic stem cell transplantation for systemic scleroderma

    Autologous hematopoietic stem cell transplantation for systemic scleroderma by R T Alekperov, L P Ananyeva

    Published 2012-08-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Lansap in treatment of esophagitis in patients with systemic sclerosis

    Lansap in treatment of esophagitis in patients with systemic sclerosis by R T Alekperov, A E Karateev, N G Guseva

    Published 2003-04-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Bone marrow mesenchymal cells: Promises for use in rheumatic diseases

    Bone marrow mesenchymal cells: Promises for use in rheumatic diseases by Lidia Petrovna Ananyeva, R T Alekperov, E L Nasonov

    Published 2013-02-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    CLINICAL ASSOCIATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS TYPE 2 RECEPTOR IN SYSTEMIC SCLEROSIS

    CLINICAL ASSOCIATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS TYPE 2 RECEPTOR IN SYSTEMIC SCLEROSIS by R. T. Alekperov, L. P. Ananyeva, M. V. Cherkasova

    Published 2018-11-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    TRADITIONAL RISK FACTORS FOR CARDIOVASCULAR DISEASES IN SYSTEMIC SCLEROSIS AND THEIR RELATIONSHIP TO STRUCTURAL CHANGES OF THE HEART

    TRADITIONAL RISK FACTORS FOR CARDIOVASCULAR DISEASES IN SYSTEMIC SCLEROSIS AND THEIR RELATIONSHIP TO STRUCTURAL CHANGES OF THE HEART by E. O. Saad, L. P. Ananyeva, D. S. Novikova, R. T. Alekperov

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Tumor necrosis factor a and its soluble receptors in rheumatic diseases: clinical and pathogenetic significance

    Tumor necrosis factor a and its soluble receptors in rheumatic diseases: clinical and pathogenetic significance by O A Krichevskaya, N G Klyukvina, E N Alexandrova, R. T. Alekperov, E. L. Nasonov

    Published 2005-04-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT

    UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT by R. T. Alekperov, E. O. Cheremukhina, L. P. Ananyeva, O. A. Koneva, V. N. Lesnyak

    Published 2014-09-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    EFFECT OF AT ORVASTATIN ON THE TIME COURSE OF CHANGESIN INFLAMMATORY MARKERS IN SYSTEMIC SCLERODERMA

    EFFECT OF AT ORVASTATIN ON THE TIME COURSE OF CHANGESIN INFLAMMATORY MARKERS IN SYSTEMIC SCLERODERMA by R T Alekperov, E G Korzeneva, E G Aleksandrova, A A Novikov, L P Anan'eva, E L Nasonov, R T Alekperov, E G Korzeneva, E G Aleksandrova, A A Novikov, L P Ananyeva, E L Nasonov

    Published 2011-04-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    STRUCTURAL AND FUNCTIONAL CHANGES EVALUATED BY ECHOCARDIOGRAPHY IN PATIENTS WITH SYSTEMIC SCLEROSIS AND HEART RATE VARIABILITY

    STRUCTURAL AND FUNCTIONAL CHANGES EVALUATED BY ECHOCARDIOGRAPHY IN PATIENTS WITH SYSTEMIC SCLEROSIS AND HEART RATE VARIABILITY by E. O. Saad, L. P. Ananyeva, R. T. Alekperov, D. S. Novikova, Yu. O. Korsakova, A. V. Volkov

    Published 2017-03-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Bone mineral density in patients with systemic scleroderma

    Bone mineral density in patients with systemic scleroderma by O. V. Dobrovolskaya, N. V. Demin, A. V. Smirnov, L. A. Garzanova, N. V. Toroptsova, R. T. Alekperov

    Published 2019-03-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Profile of autoantibodies in systemic sclerosis

    Profile of autoantibodies in systemic sclerosis by M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, R. T. Alekperov, M. V. Cherkasova, E. N. Aleksandrova, L. P. Ananyeva

    Published 2016-10-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Comparative characteristics of the main phenotypes of systemic sclerosis

    Comparative characteristics of the main phenotypes of systemic sclerosis by R. U. Shayakhmetova, L. P. Ananyeva, M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, L. A. Garzanova, M. V. Cherkasova, R. T. Alekperov

    Published 2020-02-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA

    STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA by O A Koneva, L P Ananyeva, O B Ovsyannikova, L V Teplova, M N Starovoitova, O V Desinova, T A Nevskaya, R T Alekperov, E G Lyubimova, L N Denisov

    Published 2011-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: